Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-29

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's olopatadine hydrochloride as an original application (generic) for ophthalmic use in allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)